SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses

Nathan D. Mathewson,Hideaki Fujiwara,Shin-Rong Wu,Tomomi Toubai,Katherine Oravecz-Wilson,Yaping Sun,Corinne Rossi,Cynthia Zajac,Yi Sun,Pavan Reddy

DOI: https://doi.org/10.1016/j.ajpath.2016.06.014

2016-01-01

Abstract:Neddylation is a crucial post-translational modification that depends on the E3 cullin ring ligase (CRL). The E2-adapter component of the CRL, sensitive to apoptosis gene (SAG), is critical for the function of CRL-mediated ubiquitination; thus, the deletion of SAG regulates neddylation. We examined the role of SAG-dependent neddylation in T-cell mediated immunity using multiple approaches: a novel T-cell specific, SAG genetic knockout (KO) and chemical inhibition with small-molecule MLN4924. The KO animals were viable and showed phenotypically normal mature T-cell development. However, in vitro stimulation of KO T cells revealed significantly decreased activation, proliferation, and T-effector cytokine release, compared with WT. Using in vivo clinically relevant models of allogeneic bone marrow transplantation also demonstrated reduced proliferation and effector cytokine secretion associated with markedly reduced graft-versus-host disease. Similar in vitro and in vivo results were observed with the small-molecule inhibitor of neddylation, MLN4924. Mechanistic studies demonstrated that SAG-mediated effects in T cells were concomitant with an increase in suppressor of cytokine signaling, but not NF-kappa B translocation. Our studies suggest that SAG is a novel molecular target that regulates T-cell responses and that inhibiting neddylation with the clinically available small-molecule MLN4924 may represent a novel strategy to mitigate I-cell mediated immunopathologies, such as graft-versus host disease.